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Background: Resistant hypertension (RH) is associated with increased risk for cardiovascular events and mortality. The growing prevalence of 
hypertension and the aging population highlights the need for effective blood pressure (BP) lowering therapies for patients of all ages. 
methods: Data from patients (pts) enrolled on Symplicity HTN-1 or Symplicity HTN-2 who completed 24 months follow-up after catheter renal 
denervation (RDN) were pooled and analyzed according to age ≥65 yrs and <65 yrs. All pts had RH defined as a systolic BP (SBP) ≥160 mmHg while 
on ≥3 antihypertensive medications including a diuretic. The change from baseline BP and pulse pressure (PP) was assessed for each subset at each 
time point. 
results: There were 169 pts <65 yrs old (mean 51.7) and 73 pts ≥65 yrs old (mean 70.2). Fewer pts < 65 yrs were female (38.7% vs 45.2%), 
diabetic (29.6% vs 41.1%) or had a history of CAD (4.7% vs 12.3%). Older pts had a lower baseline diastolic BP and higher PP. Both BP and PP were 
significantly reduced after RDN. Renal function was unchanged from baseline. 
conclusions: RDN results in similar, significant BP and PP reductions for patients of all ages with no attenuation of effect through 24 months. 
Changes in PP were primarily related to reductions in SBP which may be important for preservation of myocardial perfusion pressure in older 
patients. 
Patients <65 yrs Patients ≥65 yrs
BP (mmHg) PP (mmHg) BP (mmHg) PP (mmHg)
Baseline
178 ± 17/
102 ± 14 (167)
76 ± 14 (167)
179 ± 19/
88 ± 12 (72)
90 ±18 (72)
1 Month
-19 ± 19/
-9 ± 12 (159)
-10 ± 14 (159)
-19 ± 23/
-8 ± 11 (72)
-12 ± 17 (72)
6 Months
-24 ± 23/
-11 ± 13 (158)
-13 ± 16 (158)
-24 ± 24/
-8 ± 12 (70)
-16 ± 20 (70)
12 Months
-26 ± 23/
-13 ± 14 (147)
-13 ± 16 (147)
-27 ± 27/
-10 ± 11 (65)
-17 ± 20 (65)
24 Months
-31 ± 23/
-14 ± 15 (106)
-16 ± 14 (106)
-28 ± 23/
-11 ± 12 (43)
-16 ± 18 (43)
mean±SD (n) p<0.01 for all changes from baseline
